Skip to main content

Want a detailed portfolio tracker?

Psyence Biomedical (PBM) P/E (2025 - 2026)

Psyence Biomedical (PBM) P/E from Sep 30, 2025 to Jun 3, 2026. The TTM Psyence Biomedical (PBM) P/E is -10.86. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Psyence Biomedical (PBM)

YearP/EChange
2026-10.86-86.58%
2025-80.92N/A

Comparison Psyence Biomedical (PBM) P/E with competitors

Psyence Biomedical (PBM) P/E is -10.86.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.10-100.94%
ENLVEnlivex Therapeutics Ltd0.15-101.38%
FGENFibroGen Inc0.24-102.21%
TRAWTraws Pharma Inc0.47-104.35%
FBIOFortress Biotech Inc0.71-106.50%
CHRSCoherus Biosciences Inc0.98-109.01%
ORMPOramed Pharmaceuticals Inc1.47-113.57%
AGENAgenus Inc2.05-118.86%
VIVSVivoSim Labs Inc2.54-123.35%
INVAInnoviva Inc3.19-129.36%
CRMDCorMedix Inc3.65-133.56%
ABEOAbeona Therapeutics Inc4.20-138.71%
VXRTVaxart Inc4.26-139.24%
CVACCureVac N.V.4.45-140.93%
SRPTSarepta Therapeutics Inc4.62-142.57%
GLPGGalapagos NV4.86-144.73%
RIGLRigel Pharmaceuticals4.92-145.29%
ZVRAZevra Therapeutics Inc4.97-145.79%
ABUSArbutus Biopharma Corp5.69-152.42%
CGENCompugen Ltd7.38-167.98%
AUPHAurinia Pharmaceuticals Inc9.25-185.18%
ACADAcadia Pharmaceuticals Inc9.59-188.28%
OMEROmeros Corporation9.88-190.99%
PLXProtalix BioTherapeutics Inc9.91-191.23%
SPROSpero Therapeutics Inc10.73-198.83%
ADMAAdma Biologics Inc11.33-204.32%
SVASinovac Biotech Ltd11.44-205.29%
TBPHTheravance Biopharma Inc11.78-208.43%
HRMYHarmony Biosciences Holdings Inc12.18-212.14%
TGTXTG Therapeutics Inc13.18-221.34%
INCYIncyte Corp13.38-223.21%
SABSSAB Biotherapeutics Inc14.06-229.43%
XOMAXOMA Corp14.95-237.60%
REGNRegeneron Pharmaceuticals Inc14.98-237.92%
EXELExelixis Inc15.79-245.42%
NAGENiagen Bioscience Inc16.35-250.58%
CPRXCatalyst Pharmaceuticals Inc17.34-259.69%
MDXGMimedx Group Inc17.38-259.97%
ARGXArgen X SE23.07-312.42%
HALOHalozyme Therapeutics Inc23.20-313.60%
XOMAOXOMA Corp25.34-333.35%
VRTXVertex Pharmaceuticals Inc25.66-336.21%
XOMAPXOMA Corp25.67-336.34%
CTMXCytomX Therapeutics Inc25.70-336.60%
ASNDAscendis Pharma A/S26.35-342.64%
RPRXRoyalty Pharma plc - Class A27.50-353.15%
SLNOSoleno Therapeutics Inc29.02-367.14%
LGNDLigand Pharmaceuticals Inc - Class B30.19-377.92%
BMRNBiomarin Pharmaceutical Inc37.51-445.32%
APLSApellis Pharmaceuticals Inc39.02-459.26%
KRYSKrystal Biotech Inc39.70-465.49%
GMABGenmab40.20-470.15%
ONCBeiGene Ltd67.03-717.11%
TECHBio-Techne Corp68.59-731.55%
VCELVericel Corp80.63-842.34%
PHARPharming Group N.V.87.74-907.81%
ALNYAlnylam Pharmaceuticals Inc124.93-1250.25%
TLXTelix Pharmaceuticals Ltd139.89-1387.96%
CORTCorcept Therapeutics Inc158.39-1558.27%